FIBROGEN INC
FGENOther · Non-accelerated filer<br>Smaller reporting company · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $6.4M | $29.6M | $46.8M | $140.7M | $235.3M | $176.3M |
| Operating income | −$45.9M | −$150.4M | −$322.7M | −$301.0M | −$288.5M | −$191.9M |
| Net income | $183.5M | −$47.6M | −$284.2M | −$293.7M | −$290.0M | −$189.3M |
| Total assets | $119.6M | $214.5M | $423.5M | $610.1M | $773.8M | $826.8M |
| Total liabilities | $115.1M | $398.2M | $585.7M | $611.6M | $544.7M | $385.4M |
| Equity | −$30.0M | −$225.6M | −$204.2M | −$21.4M | $209.1M | $422.2M |
| EPS (diluted) | $45.37 | $-11.89 | $-2.92 | $-3.14 | $-3.14 | $-2.11 |
| Shares out. | 100.9M | 98.8M | 94.2M | 93.0M | 91.6M | 88.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −712.7%
- Net margin
- 2848.6%
- Return on equity
- −610.7%
- Return on assets
- 153.4%
- Return on capital (ROCE)
- −50.8%
- Liabilities / assets
- 96.3%
- Debt / equity
- —
- Book value / share
- $-0.30
- Revenue growth (YoY)
- −78.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -45.53distress
- Accruals / assets
- 157.4%high accruals
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 5 warning● 0 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Armistice Capital, LlcPassive (13G)May 15, 2026
- Vanguard Group IncPassive (13G)Jul 29, 2025
- Primecap Management Co/Ca/Passive (13G)Feb 13, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Wettig ThaneOfficer — CEO | May 14, 2026 | Buy | 2,800 | $7.09 |
| Wettig ThaneOfficer — CEO | Mar 6, 2026 | Tax withholding | 277 | $6.84 |
| Delucia DavidOfficer — Chief Financial Officer | Mar 6, 2026 | Tax withholding | 60 | $6.84 |
| Delucia DavidOfficer — Chief Financial Officer | Dec 6, 2025 | Tax withholding | 52 | $8.42 |
| Wettig ThaneOfficer — CEO | Dec 6, 2025 | Tax withholding | 259 | $8.42 |
| Wettig ThaneOfficer — CEO | Nov 13, 2025 | Buy | 1,000 | $9.18 |
| Delucia DavidOfficer — Chief Financial Officer | Jun 6, 2025 | Tax withholding | 51 | $7.83 |
| Wettig ThaneOfficer — CEO | Jun 6, 2025 | Tax withholding | 246 | $7.83 |
| Schoeneck James ADirector | Jun 30, 2025 | Buy | 23,567 | $5.07 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Dec 31, 2025 | 113,045 | 3.6 | -13.9% |
| Dec 15, 2025 | 131,345 | 2.9 | -3.4% |
| Nov 28, 2025 | 135,894 | 4.2 | -7.3% |
| Nov 14, 2025 | 146,531 | 3.1 | +39.9% |
| Oct 31, 2025 | 104,776 | 6.5 | +0.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 11, 2026
- Delisting / listing-standard noticeApr 9, 2026
- Results of operationsMar 16, 2026
- Amended charter or bylaws · Other material eventJan 7, 2026
- Results of operationsNov 10, 2025
- Other material eventNov 6, 2025
- Completed an acquisition or dispositionSep 5, 2025
- Other material eventSep 2, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.